CDEK
← All organizations

Millendo Therapeutics, Inc.

For profitWebsite ↗

Also known as: Millendo Therapeutics, Inc. | Millendo Therapeutics SAS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Jul 1, 2013

Last known activity

Mar 26, 2019

Acquired by Tempest Therapeutics on Mar 29, 2021

Timeline

2010s

  1. Jun 1, 2011

    Millendo Therapeutics, Inc.— Founded

  2. Dec 20, 2017

    Alizé Pharma— Acquired

  3. Aug 10, 2018

    OvaScience— Acquired

2020s

  1. Mar 29, 2021

    Tempest Therapeutics— Acquired By

Drugs by trial phase (4 distinct, 7 trials)

Phase 3 (0 own, 1 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (7)

Details

Founded
Ann Arbor, MI, US Jun 1, 2011
Last known activity
Mar 26, 2019